Microbiology

  1. Identification of eight SARS-CoV-2 ORF7a deletion variants in 2,726 clinical specimens

    1. Sun Hee Rosenthal
    2. Ron M. Kagan
    3. Anna Gerasimova
    4. Ben Anderson
    5. David Grover
    6. Michael Hua
    7. Yan Liu
    8. Renius Owen
    9. Felicitas Lacbawan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker

    1. Yuning Chen
    2. Ya-Nan Zhang
    3. Renhong Yan
    4. Guifeng Wang
    5. Yuanyuan Zhang
    6. Zhe-Rui Zhang
    7. Yaning Li
    8. Jianxia Ou
    9. Wendi Chu
    10. Zhijuan Liang
    11. Yongmei Wang
    12. Yi-Li Chen
    13. Ganjun Chen
    14. Qi Wang
    15. Qiang Zhou
    16. Bo Zhang
    17. Chunhe Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Generation of a SARS-CoV-2 Replicon as a Model System to Dissect Virus Replication and Antiviral Inhibition

    1. Xi He
    2. Shuo Quan
    3. Min Xu
    4. Silveria Rodriguez
    5. Shih Lin Goh
    6. Jiajie Wei
    7. Arthur Fridman
    8. Kenneth A. Koeplinger
    9. Steve S. Carroll
    10. Jay A. Grobler
    11. Amy S. Espeseth
    12. David B. Olsen
    13. Daria J. Hazuda
    14. Dai Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Effect of RBD mutation (Y453F) in spike glycoprotein of SARS-CoV-2 on neutralizing antibody affinity

    1. Takuma Hayashi
    2. Nobuo Yaegashi
    3. Ikuo Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households

    1. Matthieu Fritz
    2. Béatrice Rosolen
    3. Emilie Krafft
    4. Pierre Becquart
    5. Eric Elguero
    6. Oxana Vratskikh
    7. Solène Denolly
    8. Bertrand Boson
    9. Jessica Vanhomwegen
    10. Meriadeg Ar Gouilh
    11. Angeli Kodjo
    12. Catherine Chirouze
    13. Serge Rosolen
    14. Vincent Legros
    15. Eric M. Leroy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro

    1. Kaho Shionoya
    2. Masako Yamasaki
    3. Shoya Iwanami
    4. Yusuke Ito
    5. Shuetsu Fukushi
    6. Hirofumi Ohashi
    7. Wakana Saso
    8. Tomohiro Tanaka
    9. Shin Aoki
    10. Kouji Kuramochi
    11. Shingo Iwami
    12. Yoshimasa Takahashi
    13. Tadaki Suzuki
    14. Masamichi Muramatsu
    15. Makoto Takeda
    16. Takaji Wakita
    17. Koichi Watashi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. MRCA time and epidemic dynamics of the 2019 novel coronavirus

    1. Chi Zhang
    2. Mei Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Susceptibility of domestic swine to experimental infection with SARS-CoV-2

    1. Brad S. Pickering
    2. Greg Smith
    3. Mathieu M. Pinette
    4. Carissa Embury-Hyatt
    5. Estella Moffat
    6. Peter Marszal
    7. Charles E. Lewis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Proteolytic activation of SARS-CoV-2 spike at the S1/S2 boundary: potential role of proteases beyond furin

    1. Tiffany Tang
    2. Javier A. Jaimes
    3. Miya K. Bidon
    4. Marco R. Straus
    5. Susan Daniel
    6. Gary R. Whittaker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Liquid chalk is an antiseptic against SARS-CoV-2 and influenza A respiratory viruses

    1. Julie L. McAuley
    2. Joshua M. Deerain
    3. William Hammersla
    4. Turgut E. Aktepe
    5. Damian J.F. Purcell
    6. Jason M. Mackenzie

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 176 of 252 Next